RICH PHARMACEUTICALS, INC.
RICH PHARMACEUTICALS, INC.
BEVERLY HILLS, CA
Loading...
Price History
Market Data
| Market Cap | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 0.00 |
| Currency | USD |
Key Financial Metrics
-
Revenue
-1.69M
Net Income
-
EPS (Diluted)
-978,341.00
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
-
EBITDA
-1.34M
Returns & Efficiency
Return on Assets (ROA)
-4521.5%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-
Financial Health
Total Assets
37,429.00
Total Debt
-
Debt to Equity
-
Current Ratio
0.00
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | BEVERLY HILLS, CA |
| Fiscal Year | 2017 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
533.28B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin-
Net Margin-
ROE-
ROA-4521.5%
Leverage & Liquidity
Debt to Equity-
Current Ratio0.00
Total Debt-
Total Assets$37.43K
Stockholders' Equity$-6.36M
Income Statement (FY 2017)
Revenue-
Gross Profit-
Operating Income$-1.34M
Net Income$-1.69M
EPS (Diluted)-
Cash Flow (FY 2017)
Free Cash Flow$-978.34K
Cash & Equivalents$6.22K
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS, CA 90212 |
| Phone | (424) 230-7001 |
| Incorporated | WY, US |
| EIN | 463259117 |
| Fiscal Year End | 0331 |
| Stockholders' Equity | $-6.36M |
| Cash & Equivalents | $6.22K |
Recent Filings
View All
REVOKED
REVOKED Filing
SEC regulatory filing
Filed: 2021-10-29
8-K
Current Report
2021-07-01 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2021-07-06
8-K
Current Report
2019-06-11 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2019-07-03
RW
Registration Withdrawal
Request for withdrawal of registration
Filed: 2019-03-19
8-K
Current Report
2019-02-12 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2019-02-12
10-K
Annual Report
2018-03-31 • Comprehensive annual financial report with audited statements
Filed: 2018-07-17
View
NT 10-K
Late Filing Notice (10-K)
2018-03-31 • Notification of late annual report filing
Filed: 2018-07-02
8-K
Current Report
2018-04-10 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2018-04-13
8-K
Current Report
2018-03-15 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2018-03-23
DEF 14C
Definitive Information Statement
2018-02-28 • Information statement when no proxy solicitation
Filed: 2018-03-15
8-K
Current Report
2018-03-02 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2018-03-12
PRE 14C
Preliminary Information Statement
2018-02-21 • Preliminary information statement
Filed: 2018-03-02
8-K
Current Report
2018-02-09 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2018-02-26
10-Q
Quarterly Report
2017-12-31 • Quarterly financial report with unaudited statements
Filed: 2018-02-20
View
NT 10-Q
Late Filing Notice (10-Q)
2017-12-31 • Notification of late quarterly report filing
Filed: 2018-02-15
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | RICH PHARMACEUTICALS, INC. |
| Ticker | None |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | BEVERLY HILLS, CA |
| Fiscal Year | 2017 |
Financial Summary
| Market Cap | - |
| Revenue | - |
| Net Income | -1.69M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | - |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...